Ryan Specialty Holdings financials
$37.85−0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.99B | $2.46B | $2.03B | $1.71B | $1.43B |
| Gross profit | $1.19B | $864.6M | $705.6M | $582.9M | $1.43B |
| Gross margin | 39.8% | 35.2% | 34.8% | 34.0% | 100.0% |
| Operating income | $437.1M | $367.8M | $308.1M | $276.2M | $186.0M |
| Net income | $63.4M | $94.7M | $61.0M | $61.9M | -$7.1M |
| Net margin | 2.1% | 3.9% | 3.0% | 3.6% | −0.5% |
| Diluted EPS | $0.47 | $0.71 | $0.52 | $0.52 | $-0.07 |
| EBITDA | $724.6M | $535.4M | $424.0M | $385.9M | $301.6M |
| Operating cash flow | $643.7M | $514.9M | $477.2M | $335.5M | $273.5M |
| Free cash flow | $572.7M | $467.9M | $447.4M | $312.8M | -$79.4M |
| Diluted shares | 138.2M | 132.9M | 125.7M | 265.8M | 105.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $158.3M | $540.2M | $838.8M | $992.7M | $387.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $3.35B | $3.28B | $1.98B | $1.98B | $1.59B |
| Total assets | $10.56B | $9.65B | $7.25B | $6.38B | $5.46B |
| Total liabilities | $9.31B | $8.55B | $6.27B | $5.57B | $4.86B |
| Shareholders' equity | $1.25B | $1.10B | $979.6M | $817.8M | $594.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology